-
DeVico's idea was to build a vaccine consisting of gp120 permanently fused to its CD4 receptor.
FORBES: Outsmarting AIDS
-
But gp120's innards are exposed for 30 minutes or so while the protein is hooked to its human receptor, called CD4, in preparation to invade a cell.
FORBES: Outsmarting AIDS
-
Prof Jonathan Weber, from Imperial College London, said those on the 48-week regime "end up with much higher CD4 cell count and a much lower viral load".
BBC: Early HIV drugs 'slow virus down'
-
The researchers used a sophisticated statistical modeling technique to assess viral load and CD4 cell loss in more than 2, 800 patients with HIV who were not receiving treatment.
BBC: Cell infected with HIV
-
Those taking the drug also had a higher CD4 count.
BBC: Cell infected with HIV
-
Eventually, he began to study an antibody called Ibalizumab that was designed to block HIV from attaching to CD4, the primary receptor used by the virus to infect a cell.
FORBES: Progress in Drug Therapy Marks the 25th Anniversary of World AIDS Day
-
This consists of two sugar-protein molecules known as gp120 and gp41 that react with a protein called CD4, which is found on the surface of certain cells of the immune system.
ECONOMIST: AIDS vaccines
-
Two specific types of immune system cell that attack invaders - CD4 T-cells and natural killer cells - increased in number with age, with a higher rate of increase in women than in men.
BBC: Biological clue to why women live longer than men
-
Edwin Bernard, editor of AIDS Treatment Update, said it was known that CD4 decline varied enormously between people with a similar viral load, and that treatment guidelines had begun to play down the importance of the measure as a diagnostic tool.
BBC: Cell infected with HIV